NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cryosa

Cryosa

Private
Arden Hills, MinnesotaHealthcare & Life Scienceshttps://cryosa.com/

Last Round

Series B

Sep 23, 2021

Total Funding Raised

$34.25M

Company Overview

Cryosa is a clinical-stage medical device company developing a minimally invasive, incisionless treatment for moderate to severe Obstructive Sleep Apnea (OSA).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

OSAobstructive sleep apneaneurostimulationsleep apnea implantimplantable medical deviceCPAP alternativehypoglossal nerve stimulationsleep apnea treatmentminimally invasive surgerymedical deviceclinical-stage medtechairway patencysleep medicineclinical trialsotolaryngology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cryosa Comparables

Compare Cryosa with similar companies based on industry and business-model similarity.

Cryosa comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
XII Medical
91%
Lunair Medical
89%
Nyxoah
84%

Cryosa Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 23, 2021
Series A ExtensionJun 25, 2020
Series AMay 29, 2019
Series AApr 20, 2018

Key People

Founding team and executive leadership

Donald Gonzales

Founder, CMO and Director

Founding Team

Laura Stoltenberg

Chief Executive Officer

Executive Team

Cryosa Investors

Notable investors and investment history

Cryosa investors
InvestorRounds
Santé VenturesSeries B, Series A Extension
Santé VenturesSeries B, Series A, Series A Extension
Solas BioVenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 23, 2021

    $22M round led by Solas BioVentures.

  • Jun 25, 2020

    $8.25M round led by Santé Ventures and HOYA Corporation.

Cryosa Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cryosa Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cryosa's valuation, stock price, and market status.

Firmographic Details

HeadquartersArden Hills, Minnesota
Employee Range13
Year Founded2014
Last FundingSep 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.